Quantifying longitudinal & regional changes in Aβ can improve the prediction of cognitive functioning

The value of quantitative longitudinal and regional amyloid beta (Aβ) measurements in predicting cognitive decline in initially cognitively unimpaired (CU) individuals remains to be determined.
Researchers selected 133 CU individuals with two or more [11C]Pittsburgh compound B ([11C]PiB) scans and neuropsychological data from Open Access Series of Imaging Studies (OASIS-3). Baseline and annualized distribution volume ratios were computed for a global composite and four regional clusters. The predictive value of Aβ measurements (baseline, slope, and interaction) on longitudinal cognitive performance was examined.
Global performance could only be predicted by Aβ burden in an early cluster (precuneus, lateral orbitofrontal, and insula) and the precuneus region of interest (ROI) by itself significantly improved the model. Precuneal Aβ burden was also predictive of immediate and delayed episodic memory performance. In Aβ subjects at baseline (= 93), lateral orbitofrontal Aβ burden predicted working and semantic memory performance.
Quantifying longitudinal and regional changes in Aβ can improve the prediction of cognitive functioning in initially CU individuals.
The research leading to these results has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No. 115952. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation program and EFPIA.
Read the full paper here: https://doi.org/10.1002/dad2.12216
This post is part of our annual campaign entitled “Programme impact analysis – Where we are and where we need to go”. Follow the whole campaign here. Liduine Colij 2021_Neuronet_Social Media Campaign